Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

Open access
Petrasek, Jan, Bala, Shashi, Csak, Timea, Lippai, Dora, Kodys, Karen, Menashy, Victoria, Barrieau, Matthew, Min, So-Yun, Kurt-Jones, Evelyn A., Szabo, Gyongyi · 2012 · Journal of Clinical Investigation

Abstract

Alcoholic liver disease (ALD) is characterized by steatosis and upregulation of proinflammatory cytokines, including IL-1β. IL-1β, type I IL-1 receptor (IL-1R1), and IL-1 receptor antagonist (IL-1Ra) are all important regulators of the IL-1 signaling complex, which plays a role in inflammation. Furthermore, IL-1β maturation is dependent on caspase-1 (Casp-1). Using IL-1Ra-treated mice as well as 3 mouse models deficient in regulators of IL-1β activation (Casp-1 and ASC) or signaling (IL-1R1), we found that IL-1β signaling is required for the development of alcohol-induced liver steatosis, inflammation, and injury. Increased IL-1β was due to upregulation of Casp-1 activity and inflammasome activation. The pathogenic role of IL-1 signaling in ALD was attributable to the activation of the inflammasome in BM-derived Kupffer cells. Importantly, in vivo intervention with a recombinant IL-1Ra blocked IL-1 signaling and markedly attenuated alcohol-induced liver inflammation, steatosis, and damage. Furthermore, physiological doses of IL-1β induced steatosis, increased the inflammatory and prosteatotic chemokine MCP-1 in hepatocytes, and augmented TLR4-dependent upregulation of inflammatory signaling in macrophages. In conclusion, we demonstrated that Casp-1-dependent upregulation of IL-1β and signaling mediated by IL-1R1 are crucial in ALD pathogenesis. Our findings suggest a potential role of IL-1R1 inhibition in the treatment of ALD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci60777

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 3

  1. Thurman, 1998, Am J Physiol., 275, G605
  2. Mertens, 2009, Cochrane Database Syst Rev., CD005121
  3. Imaeda, 2009, J Clin Invest., 119, 305

Cited by

See all 749

Metadata

Authors
Petrasek, J., Bala, S., Csak, T., Lippai, D., Kodys, K., Menashy, V., Barrieau, M., Min, S.-Y., Kurt-Jones, E. A., & Szabo, G.
Affiliations
University of Massachusetts Chan Medical School (US)
Venue
Journal of Clinical Investigation
Published
2012-10-01
Volume
122
Issue
10
Pages
3476-3489
ISSN
0021-9738 (ISSN-L)
OpenAlex
W1975752601
Cited by
735
References
41
Citations by year
2026: 24 · 2025: 55 · 2024: 61 · 2023: 70 · 2022: 63 · 2021: 37 · 2020: 55 · 2019: 50 · 2018: 66 · 2017: 58 · 2016: 55 · 2015: 55 · 2014: 49 · 2013: 33 · 2012: 4
FWCI
6.53
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship@UMassChan (submittedVersion)
Funders
  • National Institute on Alcohol Abuse and Alcoholism (R01AA017729, AA017729)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 32520, P30DK032520)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords
interleukin-1 receptor antagonist, alcoholic steatohepatitis, alcoholic liver disease, IL-1β signaling, inflammasome, caspase-1, IL1R1, Kupffer cells, hepatic steatosis, liver inflammation, MCP-1, TLR4, macrophages, hepatocytes
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Ethanol, Animals, Carrier Proteins, Drug Evaluation, Preclinical, Fatty Liver, Alcoholic, Female, Kupffer Cells, Liver Cirrhosis, Mice, Inbred C57BL, Recombinant Proteins, Signal Transduction, Up-Regulation, Mice, Knockout, Chemokine CCL2, Caspase 1, Hepatocytes, Toll-Like Receptor 4, Mice, Receptors, Interleukin-1 Type I, Interleukin-1alpha, Interleukin-1beta, Interleukin 1 Receptor Antagonist Protein, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. https://app.cochat.ai/papers/10.1172/jci60777
The paper
Petrasek, J., Bala, S., Csak, T., Lippai, D., Kodys, K., Menashy, V., Barrieau, M., Min, S.-Y., Kurt-Jones, E. A., & Szabo, G. (2012). IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci60777

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.